Literature DB >> 2230945

Retrosplenial cortex: possible role in habituation of the orienting response.

S E Kwon1, S E Nadeau, K M Heilman.   

Abstract

A patient with a unilateral lesion that included the retrosplenial area had a propensity to attend to contralateral stimuli. To determine whether the retrosplenial-area lesion was inducing this defect, unilateral retrosplenial lesions were produced in rats by surgical aspiration. Animals were assessed preoperatively and postoperatively for orientation and habituation to bilateral simultaneous stimulation in 3 sensory modalities: visual, tactile, and auditory. At each session, the orientation test was terminated upon completion of 5 trials per modality, and the habituation test ended after 4 consecutive response failures or upon completion of 15 trials per modality. Postoperatively, contralateral orientation was not significantly different from ipsilateral orientation, suggesting that there was no neglect. However, there was a significant delay in habituation to contralateral stimulation in postoperative weeks 2 and 3-5. Our results suggest that rats with retrosplenial area lesions have normal orientation but fail to habituate to contralateral stimuli.

Entities:  

Mesh:

Year:  1990        PMID: 2230945      PMCID: PMC6570108     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  3 in total

1.  Temporary inactivation of the retrosplenial cortex causes a transient reorganization of spatial coding in the hippocampus.

Authors:  B G Cooper; S J Mizumori
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Visual Cortex: The Eccentric Area Prostriata in the Human Brain.

Authors:  Marco Tamietto; David A Leopold
Journal:  Curr Biol       Date:  2018-01-08       Impact factor: 10.834

Review 3.  Toward a conceptualization of retrohippocampal contributions to learning and memory.

Authors:  David J Bucci; Siobhan Robinson
Journal:  Neurobiol Learn Mem       Date:  2014-05-27       Impact factor: 2.877

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.